GetToolImpactFactorPageRequest(projectId=1, fullname=abc-01 is a worldwide, names=abc-01 is a worldwide, oldNames=ABC-01 is a worldwide, randomized, placebo-controlled with active treatment, parallel-group, multi-site, double-blind trial of IV ABC combined with carboplatin- paclitaxel/nab-paclitaxel chemotherapy versus saline placebo combined with carboplatin-paclitaxel/nab-paclitaxel chemotherapy in subjects with metastatic squamous non-small cell lung cancer (NSCLC) who have not previously received systemic therapy for metastatic disease., impactFactorMin=null, impactFactorMax=null, sortName=null, sortType=null, tagName=null, tagId=null, bigClassId=null, smallClassId=null, bigclass=null, smallclass=null, source=1, isHighlight=0, categoryId=null, excludeIds=null, categoryIds=null, type=sci)[]0<div class='list-no-data'><div class='no-data-img'><img src='https://img.medsci.cn/web/prod/img/no_data.png' id='noDataImg'/></div><div class='no-data-font' id='noDataFont'>暂无数据</div></div>高级检索共查询到0条结果
高级检索
